14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $68.49 $68.49 Friday, 27th Jan 2023 GBT stock ended at $68.49. During the day the stock fluctuated 0% from a day low at $68.49 to a day high of $68.49.
90 days $68.49 $68.49
52 weeks $21.65 $73.02

Historical GLOBAL BLOOD THERAPEUTICS prices

Date Open High Low Close Volume
Dec 30, 2019 $79.47 $80.12 $77.53 $79.13 637 378
Dec 27, 2019 $82.04 $82.19 $78.44 $79.15 919 389
Dec 26, 2019 $81.29 $82.93 $81.03 $81.86 1 082 527
Dec 24, 2019 $80.63 $81.76 $79.87 $81.27 456 599
Dec 23, 2019 $77.96 $80.95 $77.05 $80.23 1 081 510
Dec 20, 2019 $76.01 $77.02 $75.99 $76.87 1 478 227
Dec 19, 2019 $76.07 $76.40 $74.06 $75.81 958 507
Dec 18, 2019 $73.00 $75.87 $71.60 $75.43 2 173 673
Dec 17, 2019 $78.68 $79.25 $76.92 $77.78 681 607
Dec 16, 2019 $76.51 $78.40 $75.84 $78.06 1 089 096
Dec 13, 2019 $76.40 $77.67 $75.29 $76.88 804 820
Dec 12, 2019 $78.54 $79.46 $75.17 $76.89 1 418 282
Dec 11, 2019 $76.16 $78.51 $75.19 $78.45 1 394 580
Dec 10, 2019 $76.16 $77.94 $72.48 $75.95 2 153 628
Dec 09, 2019 $78.50 $79.95 $71.60 $75.11 3 343 282
Dec 06, 2019 $76.15 $79.74 $75.00 $79.35 1 727 540
Dec 05, 2019 $74.08 $77.95 $73.59 $76.15 1 944 208
Dec 04, 2019 $72.25 $74.43 $70.90 $74.18 1 546 805
Dec 03, 2019 $68.90 $73.23 $68.45 $72.49 2 038 236
Dec 02, 2019 $66.74 $70.50 $66.70 $69.39 1 825 403
Nov 29, 2019 $66.23 $68.76 $66.02 $66.50 928 917
Nov 27, 2019 $63.10 $71.94 $63.09 $66.26 3 964 773
Nov 26, 2019 $67.08 $69.69 $59.21 $62.99 6 114 629
Nov 25, 2019 $57.20 $61.39 $57.10 $59.95 1 699 763
Nov 22, 2019 $56.56 $57.50 $55.13 $56.14 1 245 030
Click to get the best stock tips daily for free!

About GLOBAL BLOOD THERAPEUTICS

GLOBAL BLOOD THERAPEUTICS Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses of Oxbryta in a Phase II a clinical trial of adolescent and pediatric patients with SCD. In addition, ... GBT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT